Evidence map›Paper›PMID 26670021›Full record

ArticleDer Nervenarzt2016

[Guideline-oriented treatment of alcohol-related disorders].

K Mann, E Hoch, A Batra, U Bonnet, A Günthner, G Reymann, M Soyka, N Wodarz, M Schäfer

Abstract read
PubMed Publisher
In one paragraph

Article in Der Nervenarzt, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

K MannKlinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut für Seelische Gesundheit, Medizinische Fakultät Mannheim, J 5, 68159, Mannheim, Deutschland. Karl.Mann@zi-mannheim.de.
E HochKlinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut für Seelische Gesundheit, Medizinische Fakultät Mannheim, J 5, 68159, Mannheim, Deutschland.
A BatraSektion Suchtforschung und Suchttherapie, Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Tübingen, Tübingen, Deutschland.
U BonnetKlinik für Psychiatrie, Psychotherapie und Psychosomatik, Ev. Krankenhaus Castrop-Rauxel, Castrop-Rauxel, Deutschland.
A GünthnerRehabilitationsklinik für Abhängigkeitserkrankte, Fachklinik Eußerthal, Eußerthal, Deutschland.
G ReymannSuchtabteilungen, LWL-Klinik Dortmund, Dortmund, Deutschland.
M SoykaPrivatklinik Meiringen, Meiringen, Deutschland.
N WodarzKlinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg, Bezirksklinikum Regensburg, Regensburg, Deutschland.
M SchäferKlinik für Psychiatrie, Psychotherapie und Suchtmedizin, Kliniken Essen-Mitte, Ev. Huyssens-Stiftung, Essen, Deutschland.
Central Institute of Mental Health · DEKliniken Essen-Mitte · DEKlinikum Dortmund · DERütgers (Germany) · DEUniversitätsklinikum Tübingen · DEUniversity of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcohol use disorders (e.g. abuse and dependence) account for a plethora of consequences for affected individuals and for a substantial proportion of the overall burden of disease for the community. To date, existing treatment options are either poorly known by doctors or they are not fully applied and only approximately 15% of potential patients are treated with a mean latent period of 10 years between early symptoms and the first intervention. So-called S3 treatment guidelines were recently developed to close this gap. Representatives of more than 50 learned societies, families and patients were involved. A systematic literature search from 2005 to 2012 was performed and more than 120 recommendations were made. Financing came exclusively from those societies and the academic and treatment institutes involved.This article summarizes the recommendations pertinent for psychiatrists and include early detection and intervention, acute withdrawal and long-term psychotherapy and pharmacotherapy. Classical and new treatment goals are discussed. If the new guidelines were properly applied an increase in patients receiving treatment to 30-40% could be expected, which would improve the quality of lives of affected persons and their families and in Germany would save several thousand lives per year.

Indexed as

Practice Guidelines as TopicAlcohol-Related DisordersClinical Decision-MakingEvidence-Based MedicineGermanyGuideline AdherenceHumansNeurologyPsychiatryPsychotherapyTreatment OutcomeAlcohol-related disordersEvidence based medicineTreatment guidelinesTreatment prevalenceWithdrawal treatment

Identifiers

PMID26670021
OpenAlexW2212148331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.